These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2905158)

  • 1. Review of central haemodynamic effects of alpha-blockers and their future use in hypertension.
    Omvik P; Lund-Johansen P
    Br J Clin Pract Suppl; 1987 Dec; 54():15-21. PubMed ID: 2905158
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of the haemodynamic effects of alpha- and beta-blockade in essential hypertension.
    Taylor SH
    Br J Clin Pract Suppl; 1987 Dec; 54():22-31. PubMed ID: 2905159
    [No Abstract]   [Full Text] [Related]  

  • 3. Alpha-adrenergic blockade in the treatment of essential hypertension.
    De Leeuw PW; Birkenhäger WH
    Neth J Med; 1983; 26(9):274-82. PubMed ID: 6140644
    [No Abstract]   [Full Text] [Related]  

  • 4. [The pharmacodynamic and hypotensive efficacy of proxodolol in an acute drug test on hypertension patients].
    Kukes VG; Starodubtsev AK; Smirnov MV; Petrov IN
    Eksp Klin Farmakol; 1994; 57(3):45-7. PubMed ID: 7914120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Changes of cardio- and hemodynamics during treatment of arterial hypertension with adrenergic alpha receptor blockader pyrroxane].
    Zonis BIa; Brin VB
    Ter Arkh; 1979; 51(11):28-30. PubMed ID: 42984
    [No Abstract]   [Full Text] [Related]  

  • 6. Cardiovascular effects of short-term selective alpha 1-adrenergic blockade with terazosin in patients with essential hypertension.
    Beretta-Piccoli C; Ferrier C; Weidmann P
    J Hypertens Suppl; 1985 Dec; 3(3):S231-4. PubMed ID: 2908818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypertension and alpha-adrenergic blockers: preliminary ALLHAT results.
    Chen BH
    CMAJ; 2000 Aug; 163(4):437. PubMed ID: 10976266
    [No Abstract]   [Full Text] [Related]  

  • 8. Alpha-blockers in hypertension: growing recognition as first line therapy.
    Khokhani RC
    J Assoc Physicians India; 1998; Suppl 1():7-10. PubMed ID: 11229107
    [No Abstract]   [Full Text] [Related]  

  • 9. Therapeutic options in the management of hypertension: reemerging focus on alpha blockers.
    Venkata C; Ram S
    Indian Heart J; 1993; 45(2):81-5. PubMed ID: 8103507
    [No Abstract]   [Full Text] [Related]  

  • 10. [Possibility of predicting the use of doxazosin in the treatment of arterial hypertension].
    Khlynova OV; Tuev AV; Agafonov AV; Shkliaeva LN
    Klin Med (Mosk); 2003; 81(10):48-50. PubMed ID: 14664175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The new Russian preparation proxodolol in the treatment of arterial hypertension].
    Ol'binskaia LI; Morozova TE
    Eksp Klin Farmakol; 1994; 57(3):42-5. PubMed ID: 7914119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of a new alpha- and beta-adrenoceptor blocking drug (YM-09538) on intraoperative hypertension].
    Sha K; Furuya H; Kuro M; Kitaguchi K; Yamagishi N; Marunaka S; Shimoyama J; Okuda T
    Masui; 1988 Jul; 37(7):830-5. PubMed ID: 2906709
    [No Abstract]   [Full Text] [Related]  

  • 13. Metabolic effects of alpha-blockers.
    Phadke AS
    J Assoc Physicians India; 1998; Suppl 1():15-21. PubMed ID: 11229104
    [No Abstract]   [Full Text] [Related]  

  • 14. A review of the effects of antihypertensive treatment with alpha 1-adrenoceptor antagonists on plasma lipid profiles.
    Elliott HL
    Br J Clin Pract Suppl; 1987 Dec; 54():61-8. PubMed ID: 2905161
    [No Abstract]   [Full Text] [Related]  

  • 15. [The medicinal chemistry of alpha 1 blockers].
    Ude C; Schubert-Zsilavecz M
    Pharm Unserer Zeit; 2008; 37(4):284-8. PubMed ID: 18618627
    [No Abstract]   [Full Text] [Related]  

  • 16. [Therapeutic effect of trandat, an alpha- and beta-adrenergic receptor blockader, and its effect on central, regional and intracardiac hemodynamics].
    Erina EV; Charyev KhE; Beliakova EV; Tverskaia LV; Kukharchuk VV
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1982; 5(1):68-74. PubMed ID: 6124260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Alpha-adrenergic blockade in the treatment of burn shock].
    Pekarskiĭ DE; Tsukerman MA
    Ortop Travmatol Protez; 1973 Jul; 34(7):20-4. PubMed ID: 4150645
    [No Abstract]   [Full Text] [Related]  

  • 18. [Acute effect of a new alpha 1-receptor blocking drug, E-643, on severe congestive heart failure--pharmacokinetic and hemodynamic studies].
    Itoh K; Kohya T; Nishijima H; Yasuda H; Minami S; Tsujinaga H
    Kokyu To Junkan; 1983 Oct; 31(10):1117-21. PubMed ID: 6141632
    [No Abstract]   [Full Text] [Related]  

  • 19. [The efficacy of proxodolol in patients with stable arterial hypertension].
    Metelitsa VI; Ostrovskaia TP; Duda SG; Shastun RS; Chel'dieva EIa; Simonov DV; Kalinin AL; Kekshina MS
    Eksp Klin Farmakol; 1994; 57(3):38-42. PubMed ID: 7914118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The new alpha blockers: dubious past or bright future?
    Beevers DG
    J Hum Hypertens; 1991 Aug; 5(4):307-8. PubMed ID: 1683404
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.